Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

The Role of Atrial Shunts in the Treatment of HFpEF

CME

The Role of Atrial Shunts in the Treatment of HFpEF

Managing the Growing Epidemic of HF: The Potential Role of Shunts

CME

Managing the Growing Epidemic of HF: The Potential Role of Shunts

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

Optimizing the Duration of DAPT following PCI

CME

Optimizing the Duration of DAPT following PCI

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

CME

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

Updates on Onyx ONE

CME

Updates on Onyx ONE

Evaluating the Heart Failure Patient with MR: Integrating Train Data Into Clinical Practice

CME

Evaluating the Heart Failure Patient with MR: Integrating Data Into Clinical Practice

The Treatment of Mitral Regurgitation in 2019 and Beyond

CME

The Treatment of Mitral Regurgitation in 2019 and Beyond

CME

New Clinical Data on TAVR use and Intermediate Risk Patients

CME

Recent TAVR Updates and Upcoming Studies at ACC 2016

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

CME

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Defining Cost-Effectiveness and Quality of Life for TAVR

CME

Growing Indications for TAVR in 2018 and Beyond

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

CME

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

What’s Next for Left Main PCI?

CME

What’s Next for Left Main PCI?

Latest Data on Left Main Stenting and its Implications

CME

Latest Data on Left Main Stenting and its Implications

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.